Christopher Harlow

458 total citations
9 papers, 107 citations indexed

About

Christopher Harlow is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Christopher Harlow has authored 9 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 4 papers in Infectious Diseases and 2 papers in Pharmacology. Recurrent topics in Christopher Harlow's work include Tuberculosis Research and Epidemiology (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Drug-Induced Adverse Reactions (2 papers). Christopher Harlow is often cited by papers focused on Tuberculosis Research and Epidemiology (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Drug-Induced Adverse Reactions (2 papers). Christopher Harlow collaborates with scholars based in United Kingdom and United States. Christopher Harlow's co-authors include Ara Darzi, Roberta Forlano, Lakshmana Ayaru, Mark Thursz, Nisha Patel, Michaela Vollmer, Pablo N. Perez‐Guzman, Anna Cavazza, Timothy B. Hallett and Peter Crook and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and International Journal of Eating Disorders.

In The Last Decade

Christopher Harlow

8 papers receiving 104 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Harlow United Kingdom 5 49 34 21 21 16 9 107
Muhammad Moolla South Africa 7 45 0.9× 37 1.1× 34 1.6× 19 0.9× 6 0.4× 21 118
Benjamin Disney United Kingdom 7 28 0.6× 16 0.5× 46 2.2× 19 0.9× 7 0.4× 27 120
Benoît Painvin France 7 16 0.3× 18 0.5× 15 0.7× 36 1.7× 9 0.6× 19 122
Bruno Biselli Brazil 5 40 0.8× 16 0.5× 22 1.0× 19 0.9× 9 0.6× 29 129
Nikhitha Mantri United States 9 170 3.5× 67 2.0× 34 1.6× 19 0.9× 16 1.0× 27 227
Néstor Toapanta Spain 8 60 1.2× 24 0.7× 29 1.4× 21 1.0× 3 0.2× 28 164
Syeda Anum Zahra United Kingdom 6 69 1.4× 42 1.2× 26 1.2× 29 1.4× 12 0.8× 13 167
Oscar Arturo Lozano-Cruz Mexico 4 82 1.7× 36 1.1× 16 0.8× 11 0.5× 5 0.3× 8 150
Jorge Arturo Cardona–Pérez Mexico 6 17 0.3× 28 0.8× 9 0.4× 24 1.1× 7 0.4× 15 149
Sanam Alilou Iran 7 72 1.5× 34 1.0× 13 0.6× 17 0.8× 14 0.9× 12 154

Countries citing papers authored by Christopher Harlow

Since Specialization
Citations

This map shows the geographic impact of Christopher Harlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Harlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Harlow more than expected).

Fields of papers citing papers by Christopher Harlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Harlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Harlow. The network helps show where Christopher Harlow may publish in the future.

Co-authorship network of co-authors of Christopher Harlow

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Harlow. A scholar is included among the top collaborators of Christopher Harlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Harlow. Christopher Harlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Harlow, Christopher & Kosh Agarwal. (2024). The management of chronic hepatitis B. Prescriber. 35(5). 5–8.
2.
Forlano, Roberta, Christopher Harlow, Benjamin H. Mullish, et al.. (2021). Binge‐eating disorder is associated with an unfavorable body mass composition in patients with non‐alcoholic fatty liver disease. International Journal of Eating Disorders. 54(11). 2025–2030. 7 indexed citations
3.
Harlow, Christopher, Laura Martín, Meg Coleman, et al.. (2021). Monitoring prolongation of QT interval in patients with multidrug-resistant tuberculosis and non-tuberculous mycobacterium using mobile health device AliveCor. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 26. 100293–100293. 5 indexed citations
4.
Harlow, Christopher, Jamilah Meghji, Laura Martín, Timothy Harris, & Onn Min Kon. (2020). Republished: Rifampicin induced shock during re-exposure for treatment of latent tuberculosis. Drug and Therapeutics Bulletin. 58(10). 157–159. 1 indexed citations
5.
Perez‐Guzman, Pablo N., Anna Daunt, Sujit Mukherjee, et al.. (2020). Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study. Clinical Infectious Diseases. 73(11). e4047–e4057. 60 indexed citations
6.
Harlow, Christopher, Jamilah Meghji, Laura Martín, Timothy Harris, & Onn Min Kon. (2020). Rifampicin induced shock during re-exposure for treatment of latent tuberculosis. BMJ Case Reports. 13(1). e232117–e232117. 1 indexed citations
7.
Harlow, Christopher, et al.. (2020). Endoscopic submucosal dissection: an update on tools and accessories. SHILAP Revista de lepidopterología. 13. 3331033322–3331033322. 21 indexed citations
8.
Cavazza, Anna, et al.. (2019). Experience of the implementation and outcomes of universal testing for Lynch syndrome in the United Kingdom. Colorectal Disease. 21(7). 760–766. 10 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Muhammad Moolla Breakdown of academic impact, for papers by Benjamin Disney Breakdown of academic impact, for papers by Benoît Painvin Breakdown of academic impact, for papers by Bruno Biselli Breakdown of academic impact, for papers by Nikhitha Mantri Breakdown of academic impact, for papers by Néstor Toapanta Breakdown of academic impact, for papers by Syeda Anum Zahra Breakdown of academic impact, for papers by Oscar Arturo Lozano-Cruz Breakdown of academic impact, for papers by Jorge Arturo Cardona–Pérez Breakdown of academic impact, for papers by Sanam Alilou
Rankless by CCL
2026